Clinical and Genetic Characteristics of Patients with Early-Onset Diabetes Involving at Least Two Consecutive Generations: Whole-Exome Sequencing in Probands from 25 Pedigrees.

IF 1.5 4区 医学 Q3 MEDICINE, RESEARCH & EXPERIMENTAL
Current Medical Science Pub Date : 2025-08-01 Epub Date: 2025-07-22 DOI:10.1007/s11596-025-00092-6
Chun-Qiong Ran, Ying Su, Xiong Wang, Xi Chen, Zhi-Xuan Zeng, Kun Dong, Zhe-Long Liu, Shu-Hong Hu, Yan Yang, Xue-Feng Yu, Yong Chen, Gang Yuan, Wen-Tao He
{"title":"Clinical and Genetic Characteristics of Patients with Early-Onset Diabetes Involving at Least Two Consecutive Generations: Whole-Exome Sequencing in Probands from 25 Pedigrees.","authors":"Chun-Qiong Ran, Ying Su, Xiong Wang, Xi Chen, Zhi-Xuan Zeng, Kun Dong, Zhe-Long Liu, Shu-Hong Hu, Yan Yang, Xue-Feng Yu, Yong Chen, Gang Yuan, Wen-Tao He","doi":"10.1007/s11596-025-00092-6","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The molecular mechanisms of early-onset multigenerational diabetes remain unknown. This study aimed to investigate the clinical and genetic characteristics of early-onset diabetes involving at least two consecutive generations.</p><p><strong>Methods: </strong>From 1296 inpatients with diabetes, we selected individuals who were ≤ 30 years of age and who were clinically suspected of having familial monogenic diabetes. Clinical data were collected from the probands and their family members. Whole-exome sequencing (WES) was used to identify possible causal variants for diabetes. Candidate pathogenic variants were verified by Sanger sequencing, assessed for cosegregation in family members, and evaluated on the basis of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology (ACMG/AMP) guidelines. Moreover, missense and synonymous variants were subjected to in silico pathogenicity prediction via MutationTaster and PolyPhen-2. RNAfold was used to predict RNA structural alterations for synonymous variants.</p><p><strong>Results: </strong>Twenty-five early-onset diabetes patients with a history of familial diabetes were enrolled. Pathogenic/likely pathogenic variants (p.Gly292fs in HNF1A, p.Gly245Argfs*22 in PDX1, p.Asp329His in KCNJ11, p.Leu734Phe and p.Val606Gly in WFS1) were detected in four patients, who were diagnosed accurately and treated with reasonable hypoglycemic agents based on genetic testing results. The variants of uncertain significance (ABCC8 c.3039 G > A (p.Ser1013 = Ser), MAPK8IP1 p.Gln144_Gly145insSerGln, and TBC1D4 p.Arg1249Trp) were identified in three probands.</p><p><strong>Conclusion: </strong>Patients with early-onset diabetes involving at least two consecutive generations may harbor genetic variants. Genetic testing in this population enables precision diagnosis, informs individualized treatment, and facilitates genetic counseling.</p>","PeriodicalId":10820,"journal":{"name":"Current Medical Science","volume":" ","pages":"789-798"},"PeriodicalIF":1.5000,"publicationDate":"2025-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Medical Science","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s11596-025-00092-6","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/7/22 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0

Abstract

Background: The molecular mechanisms of early-onset multigenerational diabetes remain unknown. This study aimed to investigate the clinical and genetic characteristics of early-onset diabetes involving at least two consecutive generations.

Methods: From 1296 inpatients with diabetes, we selected individuals who were ≤ 30 years of age and who were clinically suspected of having familial monogenic diabetes. Clinical data were collected from the probands and their family members. Whole-exome sequencing (WES) was used to identify possible causal variants for diabetes. Candidate pathogenic variants were verified by Sanger sequencing, assessed for cosegregation in family members, and evaluated on the basis of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology (ACMG/AMP) guidelines. Moreover, missense and synonymous variants were subjected to in silico pathogenicity prediction via MutationTaster and PolyPhen-2. RNAfold was used to predict RNA structural alterations for synonymous variants.

Results: Twenty-five early-onset diabetes patients with a history of familial diabetes were enrolled. Pathogenic/likely pathogenic variants (p.Gly292fs in HNF1A, p.Gly245Argfs*22 in PDX1, p.Asp329His in KCNJ11, p.Leu734Phe and p.Val606Gly in WFS1) were detected in four patients, who were diagnosed accurately and treated with reasonable hypoglycemic agents based on genetic testing results. The variants of uncertain significance (ABCC8 c.3039 G > A (p.Ser1013 = Ser), MAPK8IP1 p.Gln144_Gly145insSerGln, and TBC1D4 p.Arg1249Trp) were identified in three probands.

Conclusion: Patients with early-onset diabetes involving at least two consecutive generations may harbor genetic variants. Genetic testing in this population enables precision diagnosis, informs individualized treatment, and facilitates genetic counseling.

至少连续两代早发糖尿病患者的临床和遗传特征:来自25个家系的先显子全外显子组测序
背景:早发多代糖尿病的分子机制尚不清楚。本研究旨在探讨至少连续两代早发性糖尿病的临床和遗传特征。方法:选取1296例糖尿病住院患者,年龄≤30岁,临床疑似家族性单基因糖尿病患者。收集先证者及其家庭成员的临床资料。全外显子组测序(WES)用于确定糖尿病可能的因果变异。候选致病变异通过Sanger测序验证,评估家族成员的共分离,并根据美国医学遗传学和基因组学学院和分子病理学协会(ACMG/AMP)指南进行评估。此外,误义和同义变异体通过MutationTaster和polyphen2进行硅致病性预测。RNAfold用于预测同义变异体的RNA结构改变。结果:入选25例有家族性糖尿病病史的早发性糖尿病患者。4例患者检测到致病/可能致病变异(HNF1A中p.Gly292fs, PDX1中p.Gly245Argfs*22, KCNJ11中p.Asp329His, WFS1中p.Leu734Phe和p.Val606Gly),根据基因检测结果准确诊断并合理使用降糖药治疗。意义不确定的变体(ABCC8 c.3039)G > A (p.Ser1013 = Ser)、MAPK8IP1 p.Gln144_Gly145insSerGln和TBC1D4 p.Arg1249Trp)在3个先证中被鉴定出来。结论:至少连续两代的早发性糖尿病患者可能存在遗传变异。在这一人群中进行基因检测可以实现精确诊断,为个体化治疗提供信息,并促进遗传咨询。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Current Medical Science
Current Medical Science Biochemistry, Genetics and Molecular Biology-Genetics
CiteScore
4.70
自引率
0.00%
发文量
126
期刊介绍: Current Medical Science provides a forum for peer-reviewed papers in the medical sciences, to promote academic exchange between Chinese researchers and doctors and their foreign counterparts. The journal covers the subjects of biomedicine such as physiology, biochemistry, molecular biology, pharmacology, pathology and pathophysiology, etc., and clinical research, such as surgery, internal medicine, obstetrics and gynecology, pediatrics and otorhinolaryngology etc. The articles appearing in Current Medical Science are mainly in English, with a very small number of its papers in German, to pay tribute to its German founder. This journal is the only medical periodical in Western languages sponsored by an educational institution located in the central part of China.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信